S&P 500   3,897.71 (-0.11%)
DOW   31,570.49 (+0.11%)
QQQ   322.67 (-0.28%)
AAPL   127.06 (-0.57%)
MSFT   235.40 (-0.65%)
FB   265.35 (+0.17%)
GOOGL   2,081.27 (+0.56%)
TSLA   709.93 (-1.18%)
AMZN   3,147.00 (+0.03%)
NVDA   548.21 (-0.99%)
BABA   240.79 (-0.37%)
CGC   36.03 (+3.74%)
GE   13.09 (-0.15%)
MU   94.10 (-0.70%)
NIO   45.03 (-9.51%)
AMD   85.95 (-0.51%)
T   28.27 (+0.64%)
F   12.09 (+0.92%)
ACB   11.73 (+6.25%)
DIS   196.45 (+0.75%)
BA   223.23 (-0.52%)
NFLX   551.57 (+0.17%)
BAC   35.88 (+0.25%)
S&P 500   3,897.71 (-0.11%)
DOW   31,570.49 (+0.11%)
QQQ   322.67 (-0.28%)
AAPL   127.06 (-0.57%)
MSFT   235.40 (-0.65%)
FB   265.35 (+0.17%)
GOOGL   2,081.27 (+0.56%)
TSLA   709.93 (-1.18%)
AMZN   3,147.00 (+0.03%)
NVDA   548.21 (-0.99%)
BABA   240.79 (-0.37%)
CGC   36.03 (+3.74%)
GE   13.09 (-0.15%)
MU   94.10 (-0.70%)
NIO   45.03 (-9.51%)
AMD   85.95 (-0.51%)
T   28.27 (+0.64%)
F   12.09 (+0.92%)
ACB   11.73 (+6.25%)
DIS   196.45 (+0.75%)
BA   223.23 (-0.52%)
NFLX   551.57 (+0.17%)
BAC   35.88 (+0.25%)
S&P 500   3,897.71 (-0.11%)
DOW   31,570.49 (+0.11%)
QQQ   322.67 (-0.28%)
AAPL   127.06 (-0.57%)
MSFT   235.40 (-0.65%)
FB   265.35 (+0.17%)
GOOGL   2,081.27 (+0.56%)
TSLA   709.93 (-1.18%)
AMZN   3,147.00 (+0.03%)
NVDA   548.21 (-0.99%)
BABA   240.79 (-0.37%)
CGC   36.03 (+3.74%)
GE   13.09 (-0.15%)
MU   94.10 (-0.70%)
NIO   45.03 (-9.51%)
AMD   85.95 (-0.51%)
T   28.27 (+0.64%)
F   12.09 (+0.92%)
ACB   11.73 (+6.25%)
DIS   196.45 (+0.75%)
BA   223.23 (-0.52%)
NFLX   551.57 (+0.17%)
BAC   35.88 (+0.25%)
S&P 500   3,897.71 (-0.11%)
DOW   31,570.49 (+0.11%)
QQQ   322.67 (-0.28%)
AAPL   127.06 (-0.57%)
MSFT   235.40 (-0.65%)
FB   265.35 (+0.17%)
GOOGL   2,081.27 (+0.56%)
TSLA   709.93 (-1.18%)
AMZN   3,147.00 (+0.03%)
NVDA   548.21 (-0.99%)
BABA   240.79 (-0.37%)
CGC   36.03 (+3.74%)
GE   13.09 (-0.15%)
MU   94.10 (-0.70%)
NIO   45.03 (-9.51%)
AMD   85.95 (-0.51%)
T   28.27 (+0.64%)
F   12.09 (+0.92%)
ACB   11.73 (+6.25%)
DIS   196.45 (+0.75%)
BA   223.23 (-0.52%)
NFLX   551.57 (+0.17%)
BAC   35.88 (+0.25%)
Log in
NASDAQ:SRNE

Sorrento Therapeutics News Headlines

$10.27
+0.02 (+0.20 %)
(As of 03/2/2021 09:46 AM ET)
Add
Compare
Today's Range
$10.06
Now: $10.27
$11.05
50-Day Range
$7.19
MA: $11.83
$16.51
52-Week Range
$1.55
Now: $10.27
$19.39
Volume84,419 shs
Average Volume20.80 million shs
Market Capitalization$2.88 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.7

Headlines

Sorrento Therapeutics (NASDAQ SRNE) News Headlines Today

Source:
SourceHeadline
Is Sorrento Therapeutics (NASDAQ:SRNE) More Than Just A COVID-19 PlayIs Sorrento Therapeutics (NASDAQ:SRNE) More Than Just A COVID-19 Play
marketbeat.com - October 19 at 9:18 AM
Sorrento Therapeutics (NASDAQ:SRNE) Quietly Moves Higher On COVID NewsSorrento Therapeutics (NASDAQ:SRNE) Quietly Moves Higher On COVID News
marketbeat.com - October 13 at 3:34 PM
Sorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple MalignanciesSorrento Receives FDA Clearance to Start Clinical Trial of Anti-CD47 Antibody, Discovered from Fully Human G-MAB Library, for Treatment of Multiple Malignancies
finance.yahoo.com - March 2 at 9:43 AM
Sorrento Therapeutics (NASDAQ:SRNE) Trading 6% Higher Sorrento Therapeutics (NASDAQ:SRNE) Trading 6% Higher
americanbankingnews.com - March 1 at 9:00 PM
Sorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid SyndromeSorrento Therapeutics and Scilex Holding, a Majority Owned Subsidiary, Have Entered Into an Exclusive Licensing Term Sheet With Aardvark Therapeutics to Acquire Its ARD-301 For the Treatment of Chronic Pain, Fibromyalgia, and Chronic Long Haul Covid Syndrome
finance.yahoo.com - March 1 at 1:23 PM
SORRENTO INVESTIGATION INITIATED by Former...SORRENTO INVESTIGATION INITIATED by Former...
benzinga.com - February 27 at 2:21 AM
SORRENTO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNESORRENTO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sorrento Therapeutics, Inc. - SRNE
finance.yahoo.com - February 27 at 2:21 AM
Busy Week for Earnings to Start MarchBusy Week for Earnings to Start March
baystreet.ca - February 26 at 4:20 PM
Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 7.7%Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 7.7%
americanbankingnews.com - February 25 at 8:58 PM
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseSorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
msn.com - February 22 at 1:41 PM
Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 8.4%Sorrento Therapeutics (NASDAQ:SRNE) Trading Down 8.4%
americanbankingnews.com - February 18 at 8:34 PM
The Case For Sorrento Therapeutics: Its Antibody LibraryThe Case For Sorrento Therapeutics: Its Antibody Library
seekingalpha.com - February 18 at 5:15 AM
Sorrento (SRNE) to Report Q4 Earnings: Whats in the Cards?Sorrento (SRNE) to Report Q4 Earnings: What's in the Cards?
nasdaq.com - February 17 at 12:30 PM
Sorrento Therapeutics Reports Promising Data From an Uncontrolled Clinical TrialSorrento Therapeutics Reports Promising Data From an Uncontrolled Clinical Trial
finance.yahoo.com - February 12 at 2:01 PM
Comparing Sorrento Therapeutics (NASDAQ:SRNE) and BiondVax Pharmaceuticals (NASDAQ:BVXV)Comparing Sorrento Therapeutics (NASDAQ:SRNE) and BiondVax Pharmaceuticals (NASDAQ:BVXV)
americanbankingnews.com - February 12 at 12:32 AM
How Risky Are These Heavily Shorted COVID Stocks?How Risky Are These Heavily Shorted COVID Stocks?
finance.yahoo.com - February 11 at 8:02 AM
Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Down 5.1%Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Down 5.1%
americanbankingnews.com - February 10 at 8:26 PM
Sorrento: New Platform Further Underscores the Bull CaseSorrento: New Platform Further Underscores the Bull Case
finance.yahoo.com - February 9 at 6:50 PM
Lee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical CancerLee’s Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation in China for the Treatment of Recurrent or Metastatic Cervical Cancer
finance.yahoo.com - February 9 at 1:50 PM
Sorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo ClinicSorrento Announces Subsidiary Company - ADNAB, Inc. - to Develop and Commercialize ADNAB™ Platform Products for Hematological Malignancies and Solid Tumors Based on an Exclusive Technology License From the Mayo Clinic
finance.yahoo.com - February 8 at 8:00 PM
Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Up 18.3%Sorrento Therapeutics (NASDAQ:SRNE) Stock Price Up 18.3%
americanbankingnews.com - February 8 at 7:12 PM
Whether Sorrento Therapeutics Could Benefit From A Short SqueezeWhether Sorrento Therapeutics Could Benefit From A Short Squeeze
seekingalpha.com - February 5 at 12:47 PM
March 26th Options Now Available For Sorrento Therapeutics (SRNE)March 26th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - February 4 at 3:12 PM
Sorrento: Breaking Down B. Riley’s New Bullish CallSorrento: Breaking Down B. Riley’s New Bullish Call
nasdaq.com - February 1 at 10:47 PM
Update to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem CellsUpdate to 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion of Stem Cells
finance.yahoo.com - January 31 at 7:43 PM
Sorrento Therapeutics Stock Could More Than Double, Says AnalystSorrento Therapeutics Stock Could More Than Double, Says Analyst
finance.yahoo.com - January 30 at 1:09 PM
First Week of SRNE February 19th Options TradingFirst Week of SRNE February 19th Options Trading
nasdaq.com - January 29 at 2:35 PM
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC(TM) for Treatment of ICU COVID-19 PatientsSorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC(TM) for Treatment of ICU COVID-19 Patients
marketwatch.com - January 27 at 9:25 AM
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 PatientsSorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
finance.yahoo.com - January 26 at 10:24 PM
Sorrento Stock Has Multiple Catalysts in Play; Analyst Says ‘Buy’Sorrento Stock Has Multiple Catalysts in Play; Analyst Says ‘Buy’
finance.yahoo.com - January 25 at 8:17 PM
Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji Presents at B. Riley Virtual Oncology Conference (Transcript)Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji Presents at B. Riley Virtual Oncology Conference (Transcript)
seekingalpha.com - January 22 at 6:07 PM
What’s Next For Sorrento After A 35% Move In Last 5 Trading Days?What’s Next For Sorrento After A 35% Move In Last 5 Trading Days?
forbes.com - January 22 at 8:06 AM
March 5th Options Now Available For Sorrento Therapeutics (SRNE)March 5th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - January 21 at 2:32 PM
Why Sorrento Therapeuticss Stock is Up During Todays SessionWhy Sorrento Therapeutics's Stock is Up During Today's Session
msn.com - January 20 at 4:02 PM
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike ProteinSorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
finance.yahoo.com - January 19 at 11:46 PM
Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
finance.yahoo.com - January 19 at 4:36 PM
Do Options Traders Know Something About Sorrento (SRNE) Stock We Dont?Do Options Traders Know Something About Sorrento (SRNE) Stock We Don't?
finance.yahoo.com - January 19 at 4:36 PM
These Nasdaq Biotech Stocks Doubled in 2020. Heres Why Theyre Soaring on FridayThese Nasdaq Biotech Stocks Doubled in 2020. Here's Why They're Soaring on Friday
fool.com - January 16 at 9:37 AM
Sorrento Stock Could Hit $30, Says AnalystSorrento Stock Could Hit $30, Says Analyst
finance.yahoo.com - January 15 at 3:28 AM
Dr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor ConferenceDr. Henry Ji to Participate in the H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
finance.yahoo.com - January 10 at 6:15 PM
February 26th Options Now Available For Sorrento Therapeutics (SRNE)February 26th Options Now Available For Sorrento Therapeutics (SRNE)
nasdaq.com - January 7 at 4:14 PM
SRNE Feb 2021 8.500 callSRNE Feb 2021 8.500 call
uk.finance.yahoo.com - January 6 at 12:06 AM
Sorrento TherapeuticsSorrento Therapeutics
fool.com - January 6 at 12:06 AM
Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral AntigenSorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen
finance.yahoo.com - December 30 at 2:18 PM
SRNE Dec 2020 13.000 callSRNE Dec 2020 13.000 call
au.finance.yahoo.com - December 28 at 12:24 AM
SRNE Dec 2020 12.000 callSRNE Dec 2020 12.000 call
au.finance.yahoo.com - December 27 at 12:03 AM
Sorrento Pops 8% Pre-Market On FDA Application For Covid-19 TestSorrento Pops 8% Pre-Market On FDA Application For Covid-19 Test
nasdaq.com - December 23 at 5:13 PM
Noteworthy Wednesday Option Activity: SPCE, SRNE, BANoteworthy Wednesday Option Activity: SPCE, SRNE, BA
nasdaq.com - December 23 at 5:13 PM
Sorrento Up on Request for Emergency Authorization for Covid TestSorrento Up on Request for Emergency Authorization for Covid Test
finance.yahoo.com - December 23 at 5:13 PM
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street DebutThe Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
msn.com - December 23 at 12:12 PM
Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral AntigenSorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen
finance.yahoo.com - December 22 at 8:30 PM
Is SRNE A Good Stock To Buy Now?Is SRNE A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 9:52 AM
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.